Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Radford

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Urology|June 10, 2022
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical TrialSimon J Crabb, Gareth Griffiths, Denise Dunkley, et al.
Trials|September 10, 2017
Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trialJeanne Trill, Catherine Simpson, Frances Webley, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
European Child & Adolescent Psychiatry|November 1, 2017
A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible YearsEdmund J S Sonuga-Barke, Joanne Barton, David Daley, et al.
British Journal of Cancer|July 20, 2016
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC studySiân A Pugh, Megan Bowers, Alexandre Ball, et al.
Trials|July 27, 2021
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letterGareth O Griffiths, Richard FitzGerald, Thomas Jaki, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Urology|June 10, 2022
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical TrialSimon J Crabb, Gareth Griffiths, Denise Dunkley, et al.
Trials|September 10, 2017
Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trialJeanne Trill, Catherine Simpson, Frances Webley, et al.
Trials|June 21, 2020
AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trialGareth Griffiths, Richard Fitzgerald, Thomas Jaki, et al.
European Child & Adolescent Psychiatry|November 1, 2017
A comparison of the clinical effectiveness and cost of specialised individually delivered parent training for preschool attention-deficit/hyperactivity disorder and a generic, group-based programme: a multi-centre, randomised controlled trial of the New Forest Parenting Programme versus Incredible YearsEdmund J S Sonuga-Barke, Joanne Barton, David Daley, et al.
British Journal of Cancer|July 20, 2016
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC studySiân A Pugh, Megan Bowers, Alexandre Ball, et al.
Trials|July 27, 2021
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letterGareth O Griffiths, Richard FitzGerald, Thomas Jaki, et al.
The Journal of Antimicrobial Chemotherapy|August 27, 2021
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled studySaye H Khoo, Richard Fitzgerald, Thomas Fletcher, et al.
Pageof 1